Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond physical practice: Validation and feasibility of a yoga-based counselling program (YBCP) for common mental disorders.

Asian journal of psychiatry·2026
Same author

Expression patterns of risk genes associated with three evolutionarily relevant syndromes in rhesus macaque and human brains.

Translational psychiatry·2026
Same author

Plasma Glial Fibrillary Acidic Protein (GFAP) shows age-dependent associations with externalizing psychopathology and atypical brain connectivity.

Translational psychiatry·2026
Same author

Generation of iPSC line NIMHi033-A from an Indian patient with Autism Spectrum Disorder carrying mutation in DYNC1H1 gene.

Stem cell research·2026
Same author

Restrategizing health human resources for India's Public Health System.

Journal of family medicine and primary care·2026
Same author

Human tears as social chemo-signals in taming male aggression.

Journal of biosciences·2026

Related Experiment Video

Updated: May 28, 2026

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

Effectiveness of Bifrontal ECT in Practice: A Comparison with Bitemporal ECT.

Biju Viswanath1, Janardhanan C Narayanaswamy, Jagadisha Thirthalli

  • 1National Institute of Mental Health and Neuro Sciences (NIMHANS), Bangalore, Karnataka, India.

Indian Journal of Psychological Medicine
|October 25, 2011
PubMed
Summary

Bifrontal electroconvulsive therapy (BF-ECT) shows similar clinical efficacy to bitemporal ECT (BT-ECT) but may offer fewer cognitive side effects. This study supports BF-ECT as a preferred first-line treatment option.

Keywords:
Bifrontalbitemporaleffectivenesselectroconvulsive therapy

More Related Videos

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe
06:04

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe

Published on: August 16, 2024

Related Experiment Videos

Last Updated: May 28, 2026

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe
06:04

Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe

Published on: August 16, 2024

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Devices

Background:

  • Bifrontal (BF) electrode placement in electroconvulsive therapy (ECT) is explored as an alternative to conventional bitemporal (BT) and right unilateral placements, aiming to reduce cognitive side effects.
  • Previous research on BF-ECT's clinical efficacy compared to other placements has yielded contradictory results.

Purpose of the Study:

  • To compare the clinical efficacy and treatment response of bifrontal electroconvulsive therapy (BF-ECT) versus bitemporal electroconvulsive therapy (BT-ECT).
  • To evaluate seizure threshold and treatment duration between BF-ECT and BT-ECT.

Main Methods:

  • A retrospective chart review compared 105 patients receiving BF-ECT with 105 age- and sex-matched controls receiving BT-ECT.
  • Both groups received bilateral ECT at 1.5 times the seizure threshold.
  • Key metrics included the number of ECTs, hospital stay duration, seizure threshold, and treatment response, assessed by trained raters.

Main Results:

  • BF-ECT and BT-ECT demonstrated similar speed of response, indicated by comparable numbers of ECTs administered and hospital stay durations.
  • Clinical improvement scores were similar between the BF-ECT and BT-ECT groups.
  • Patients receiving BF-ECT exhibited a significantly higher seizure threshold compared to those receiving BT-ECT, even after controlling for age.

Conclusions:

  • Bifrontal electroconvulsive therapy (BF-ECT) demonstrates comparable therapeutic efficacy to bitemporal electroconvulsive therapy (BT-ECT).
  • The findings support BF-ECT as a suitable first-line electrode placement option, particularly given its potential for fewer cognitive side effects.